These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12270466)

  • 21. Viral infections in renal transplant recipients: an evolutionary problem.
    Charpentier B
    Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment and prevention of chronic viral hepatitis].
    Lumio J; Vuoristo M
    Duodecim; 1994; 110(20):1883-92. PubMed ID: 7555802
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytomegalovirus infection after liver transplantation using different prophylaxes.
    Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
    Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis update: the role of primary care practitioners in prevention, treatment, and vaccination.
    Margolis HS
    Ethn Dis; 2002; 12(1):S2-33-5. PubMed ID: 11913636
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute viral hepatitis A, B, C, D and E: epidemiology, etiology, diagnosis, course, prevention].
    Zarski JP; Leroy V; Maynard-Muet M
    Rev Prat; 1998 Sep; 48(14):1609-14. PubMed ID: 9814059
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the risk of viral infection in renal transplantation.
    Tibbles LA
    Transplant Proc; 2008 Dec; 40(10 Suppl):S48-51. PubMed ID: 19100908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Viral hepatitis--trends].
    Manciuc C; Dorobăţ C; Filip-Ciubotaru FM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):327-31. PubMed ID: 20700962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and epidemiological aspects of imported hepatitis].
    Fujisawa K; Hirakawa J
    Nihon Rinsho; 1989 Jan; 47(1):92-100. PubMed ID: 2498554
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimizing the toxicity of antilymphocyte antibody therapy.
    Pascual M; Rubin RH; Cosimi AB
    Transplant Proc; 1996 Aug; 28(4):2113-4. PubMed ID: 8769171
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of hepatitis B in special patient populations.
    Wang HS; Han SH
    Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytomegalovirus.
    Am J Transplant; 2004 Nov; 4 Suppl 10():51-8. PubMed ID: 15504213
    [No Abstract]   [Full Text] [Related]  

  • 35. New challenges in viral hepatitis.
    Thomas D; Zoulim F
    Gut; 2012 May; 61 Suppl 1():i1-5. PubMed ID: 22504915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiological aspects of viral hepatitis: immunogenicity of hepatitis B vaccine administered to children and adolescents].
    del Rey Calero J
    An R Acad Nac Med (Madr); 1992; 109(2):261-96; discussion 296-8. PubMed ID: 1463144
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients.
    Chak WL; Choi KS; Wong KM; Chan YH; Chau KF; Li CS
    Transplant Proc; 2003 Feb; 35(1):280-1. PubMed ID: 12591399
    [No Abstract]   [Full Text] [Related]  

  • 38. Effective strategies to prevent cytomegalovirus disease after renal transplantation.
    Chapman JR
    Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809
    [No Abstract]   [Full Text] [Related]  

  • 39. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of fungal and hepatitis virus infections in liver transplantation.
    Paya CV
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S47-52. PubMed ID: 11389522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.